$0.00 EPS Expected for Opsens Inc. (OPS), Amedica (AMDA) SI Decreased By 2%

June 5, 2017 - By Migdalia James

Analysts expect Opsens Inc. (TSE:OPS) to report $0.00 EPS on July, 4. It closed at $1.32 lastly. It is down 0.00% since June 5, 2016 and is . It has underperformed by 16.70% the S&P500.

Amedica Corporation (NASDAQ:AMDA) had a decrease of 2% in short interest. AMDA’s SI was 2.25M shares in June as released by FINRA. Its down 2% from 2.29 million shares previously. With 212,200 avg volume, 11 days are for Amedica Corporation (NASDAQ:AMDA)’s short sellers to cover AMDA’s short positions. The SI to Amedica Corporation’s float is 9.15%. The stock increased 1.06% or $0.003 on June 2, reaching $0.285. About shares traded. Amedica Corporation (NASDAQ:AMDA) has declined 73.26% since June 5, 2016 and is downtrending. It has underperformed by 89.96% the S&P500.

Among 2 analysts covering Amedica (NASDAQ:AMDA), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Amedica had 3 analyst reports since August 14, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, January 5 by Ladenburg Thalmann. As per Friday, August 14, the company rating was maintained by Needham. Maxim Group initiated the stock with “Buy” rating in Thursday, November 10 report.

Amedica Corporation is a commercial biomaterial company. The company has market cap of $10.45 million. The Firm is a vertically integrated silicon nitride orthopedic medical device manufacturer. It currently has negative earnings. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices.

Opsens Inc. provides fiber optic sensing technology. The company has market cap of $113.33 million. The Firm operates through two divisions: Medical and Industrial. It currently has negative earnings. In Medical segment, the Company focuses on the measure of Fractional Flow Reserve in interventional cardiology.